Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04300569 · ClinicalTrials.gov registry record
A Study to Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm Disorder
A clinical trial, sponsored by Eisai.
- Completed
- Registry status
- 37
- Enrollment target
NCT04300569 is a clinical trial that has completed, run by Eisai. The registered enrollment target is 37 participants.
The verdict
NCT04300569 has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine the signs and symptoms of irregular sleep-wake rhythm disorder (ISWRD) that are important to patients and caregivers of patients with Alzheimer's disease dementia (AD-D), AD-D with cerebrovascular disease (CVD), and/or vascular dementia (VaD) and ISWRD, and to draft an instrument or instruments to assess them.
Interventions
- OTHER Non-interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-07-09 |
| Est. Completion | 2020-09-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04300569
The ClinicalTrials.gov registry entry for NCT04300569 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-interventional is the first listed.
NCT04300569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04300569 about?
NCT04300569 is a clinical study titled "A Study to Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm Disorder". The primary purpose of this study is to determine the signs and symptoms of irregular sleep-wake rhythm disorder (ISWRD) that are important to patients and caregivers of patients with Alzheimer's disease dementia (AD-D), AD-D with cerebrovascular disease (CVD), and/or vascular dementia (VaD) and ISW...
What is the current status of trial NCT04300569?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2020-07-09. Estimated completion is 2020-09-07.
What interventions are being tested in trial NCT04300569?
The interventions under investigation include: Non-interventional (OTHER).
Who is sponsoring clinical trial NCT04300569?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.